India  

India's drug regulator to meet again on January 1 to discuss AstraZeneca vaccine

IndiaTimes Wednesday, 30 December 2020
CDSCO, India's drug regulator will meet on Friday to consider approving AstraZeneca and Oxford University's Covid-19 vaccine for emergency use. SII, the world's biggest vaccine producer, has already stockpiled about 50 million doses, enough for 25 million people.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: India reports lowest daily Covid-19 cases in nearly 6 months|Oneindia News

India reports lowest daily Covid-19 cases in nearly 6 months|Oneindia News 02:38

India's daily number of COVID-19 cases today stood at 18,732, the lowest since July 1. 279 deaths were recorded in the past 24 hours, taking the overall count since the outbreak in January to 1,47,622. With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is...

You Might Like


💡 newsR Knowledge: Other News Mentions

Central Drugs Standard Control Organisation Central Drugs Standard Control Organisation

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against..
IndiaTimes

AstraZeneca British-Swedish pharmaceutical company

Michael Gove: UK’s vaccine supply is assured [Video]

Michael Gove: UK’s vaccine supply is assured

Michael Gove says that the UK’s supply of Covid-19 vaccines for the future has been assured amid threats from the European Union of vaccine export controls on AstraZeneca doses leaving the bloc. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:48Published

India's gift of 5 lakh doses of Covid-19 vaccines reach Sri Lanka

Sri Lanka's president on Thursday welcomed the first 500,000 doses of a Covid-19 vaccine from India, which has donated the shots to eight countries in the..
IndiaTimes
Covid vaccine: Nepal thanks India as it begins immunisation, China trumped [Video]

Covid vaccine: Nepal thanks India as it begins immunisation, China trumped

Nepal launched Covid-19 immunisation after India sent vaccines. India sent 10 lakh doses of Covishield vaccines to Nepal as a gift. Nepal PM Oli thanked India and PM Modi for the vaccine consignment. The Serum Institute of India has tied up with AstraZeneca to manufacture Covishield. Thousands of Nepalese frontline workers are set to be vaccinated. Nepal PM said talks are on with India to get more vaccines at a proper price. Oli said, “We got an early chance to administer the Covid-19 vaccine. For this, I thank our neighbouring nation India, its government, the people, and especially Prime Minister Narendra Modi. They sent 10 lakh doses of vaccines to us as a grant within a week of the roll-out in India.” Meanwhile, China is yet to get clearance for its Sinopharm vaccine in Nepal. Nepal has had over 2.7 lakh total covid cases and over 2,000 deaths. Watch the full video for more.

Credit: HT Digital Content    Duration: 03:11Published

European Union demands plan from AstraZeneca to deliver promised vaccines

The discord between the EU and drug manufacturer AstraZeneca remains despite a meeting between senior figures on Wednesday, with politicians demanding a plan..
Sky News

University of Oxford University of Oxford Collegiate research university in Oxford, England

Pfizer wants India to order Covid-19 vaccine before pursuing approval

Pfizer Inc will pursue its request for India to approve its Covid-19 vaccine if the government commits to buying shots, the US drugmaker told Reuters on Monday,..
IndiaTimes

AstraZeneca to cut COVID-19 vaccine delivery to EU by 60%, reports

AstraZeneca will cut deliveries of the Oxford COVID-19 vaccine to the European Union by 60% in the first quarter of the year, according to Reuters news agency.
Sky News
Growing up in a pandemic: how are masks and lockdowns affecting babies’ development? [Video]

Growing up in a pandemic: how are masks and lockdowns affecting babies’ development?

In a world that seems to keep going in and out of lockdown, and where faces are increasingly covered up with masks, how are babies and young children adapting? Euronews asked an expert in child development at Oxford University’s BabyLab.

Credit: euronews (in English)    Duration: 03:11Published

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

PM visits Covid vaccine centre in Glasgow [Video]

PM visits Covid vaccine centre in Glasgow

Prime Minister Boris Johnson visits a Covid-19 vaccine centre in Glasgow. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:09Published
COVID pushes Portugal's hospitals to the brink [Video]

COVID pushes Portugal's hospitals to the brink

Portugal's epidemic has entered a "terrible" phase, Prime Minister Antonio Costa has admitted, and the surge in cases has left hospitals on the brink of collapse. Emily Wither reports.

Credit: Reuters Studio    Duration: 01:46Published

Man arrested after suspicious package sent to COVID vaccine plant

A man has been arrested after a suspicious package was sent to a coronavirus vaccine production facility in Wales.
Sky News
PM visits Covid test laboratory in Glasgow [Video]

PM visits Covid test laboratory in Glasgow

Prime Minister Boris Johnson visits the Lighthouse Laboratory at the Queen Elizabeth University Hospital campus in Glasgow, where coronavirus tests are processed. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:21Published
Over 25 lakh COVID vaccine doses administered by 2pm till Jan 28: Health Ministry [Video]

Over 25 lakh COVID vaccine doses administered by 2pm till Jan 28: Health Ministry

Health Secretary Rajesh Bhushan, on January 28, briefed media about the ongoing COVID vaccination drive. While addressing the media, Bhushan informed that over 25 lakh vaccine doses have been administered so far, as per data available till 2 pm today. He also said that the number of active cases are declining and there are 1,75,000 active cases in the country as of now. "A steady and declining trend is being exhibited," said Bhushan.

Credit: ANI    Duration: 01:28Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Watch: India sends doses of SII’s Covishield vaccine to Bahrain, Sri Lanka [Video]

Watch: India sends doses of SII’s Covishield vaccine to Bahrain, Sri Lanka

India once again established its position as a reliable partner in Covid-19 assistance. It dispatched Covishield to Bahrain and Sri Lanka under the Vaccine Maitri Initiative. Sri Lanka to receive a consignment of 50,400 doses, while Bahrain to get 10,800 doses. Covishield developed by Serum Institute of India was loaded to cargo aircraft at Mumbai. The cargo aircraft left Mumbai airport as per schedule at 7:55 am for Manama. The vaccine consignment for Colombo, which delayed for 15 minutes, left at 9:00 am. Meanwhile, India has supplied vaccines to its neighbours under neighbourhood first policy. Bhutan, Maldives, Nepal, Myanmar, Sri Lanka, Afghanistan, Bangladesh received vaccines. India sees international cooperation in the area of fight against Covid-19 as its duty. New Delhi has played the role of the first responder in the region.

Credit: HT Digital Content    Duration: 01:29Published
SII's vaccines reach Mumbai airport for shipping to Bahrain, Colombo [Video]

SII's vaccines reach Mumbai airport for shipping to Bahrain, Colombo

Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 28. The consignment containing COVID-19 vaccine will be dispatched to Bahrain and Colombo today. India is helping other countries with the import of COVID vaccine amid the pandemic.

Credit: ANI    Duration: 01:41Published

Related videos from verified sources

AstraZeneca row could spark an EU-UK vaccine trade war, warns MEP [Video]

AstraZeneca row could spark an EU-UK vaccine trade war, warns MEP

German MEP Peter Liese told Euronews that if AstraZeneca doesn't reverse its decision to reduce the EU's expected number of COVID-19 vaccines then there will be repercussions.

Credit: Euronews English     Duration: 12:13Published
EU demands AstraZeneca contract after delays [Video]

EU demands AstraZeneca contract after delays

The European Union is asking AstraZeneca to publish the contract it signed with the bloc on COVID-19 vaccine supplies, an EU official said on Wednesday, in an escalation of the row over delivery..

Credit: Reuters Studio     Duration: 01:18Published
COVID-19 vaccine: AstraZeneca boss hits back at EU criticism over supply delays [Video]

COVID-19 vaccine: AstraZeneca boss hits back at EU criticism over supply delays

The CEO of the British-Swedish pharmaceutical company says the EU signed its contract with the firm three months after the UK did, allowing for less time to iron out production problems.

Credit: Euronews English     Duration: 02:03Published

Related news from verified sources

Mumbai: Is a vaccine even needed for COVID, Citizens group question

Mumbai: Is a vaccine even needed for COVID, Citizens group question
Even as the nation waits for a COVID-19 vaccine with bated breath, the recently formed citizens' movement group, Awaken India, put forward a question - Is a...
Mid-Day Also reported by •IndiaTimes

US nurse who received Pfizer COVID-19 vaccine shot tests positive

An ICU nurse in San Diego, who had received Pfizer vaccine shot against COVID-19 on December 18, has tested positive for the virus. Matthew W, a 45-year-old...
Mid-Day Also reported by •Zee News

Russia will jointly produce Sputnik V vaccine with India: Envoy

Russian envoy in New Delhi Nikolay Kudashev on Monday said Moscow will jointly produce the Sputnik V vaccine for Covid-19 along with India and it will be...
IndiaTimes